NCT06848569View on ClinicalTrials.gov

Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

October 23, 2027

Study Completion Date

October 23, 2031

Conditions
Classical Hodgkin Lymphoma
Interventions
DRUG

Sintilimab in combination with AVD chemotherapy

Sintilimab in combination with AVD chemotherapy treating classical Hodgkin lymphoma

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER